Kura Oncology, Inc.
Methods of treating cancer patients with farnesyltransferase inhibitors

Last updated:

Abstract:

The present invention relates to the field of molecular biology and cancer biology. Specifically, the present invention relates to methods of treating a subject with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on HRAS mutation status in the subject.

Status:
Grant
Type:

Utility

Filling date:

2 Nov 2017

Issue date:

21 Sep 2021